Search Type: drug or dietary supplement name
Search Term: methylphenidate [extended or sustained release] (APTENSIO XR, CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, QUILLICHEW, QUILLIVANT XR, RITALIN LA)


Drug Profiles | Worst Pills, Best Pills Newsletter Articles | Additional Information from Public Citizen

Drug and Dietary Supplement Profiles

A comprehensive review of the safety and effectiveness of this drug. If the drug is not a Do Not Use product, information on adverse effects, drug interactions and how to use the medication are included.
Search results below include drug profiles where your selected drug is a secondary subject of discussion

Worst Pills, Best Pills Newsletter Articles

Search results below include Worst Pills, Best Pills Newsletter Articles where your selected drug is a secondary subject of discussion
  • Responsible Disposal of Prescription Drugs [hide all summaries]
    (May 2016)
    For various reasons, many prescribed medications go unused. Such leftover medications can pose a hazard to family members, especially young children, and the environment. Find out the best ways to safely dispose of unused prescription medications.
  • Drug Mix-Ups [hide all summaries]
    (June 2011)
    This article lists 355 drugs with names that are often confused with similar-sounding drug names. Find out what you can do to prevent getting the wrong drug.
  • A Review of ADHD Drug Lisdexamfetamine (VYVANSE) [hide all summaries]
    (January 2010)
    We list this amphetamine-like drug as DO NOT USE because it is more expensive than (and does not treat ADHD better than) older, safer alternatives (such as methylphenidate [RITALIN]).
  • Suicide Risk in Youth: Possible Strattera Connection [hide all summaries]
    (December 2005)
    The Food and Drug Administration (FDA) issued a Public Health Advisory on Sept. 29, 2005 to warn of suicidal thinking in children and adolescents being treated with atomoxetine (STRATTERA) for attention deficit hyperactivity disorder (ADHD). There is no convincing evidence that atomoxetine (STRATTERA) is as effective or as well tolerated as stimulants such as methylphenidate (CONCERTA, and others) for treatment of ADHD.
  • Liver Toxicity With New ADHD Drug Atomoxetine (STRATTERA) [hide all summaries]
    (February 2005)
    On December 17, 2004 the Food and Drug Administration (FDA) issued a new warning for atomoxetine (STRATTERA), a drug approved to treat attention deficit hyperactivity disorder (ADHD) in adults and children, to include a bolded warning about the potential for severe liver toxicity.

Additional Information from Public Citizen

Search results below include Additional Information from Public Citizen where your selected drug is a secondary subject of discussion

SHOW primary search results for methylphenidate [extended or sustained release] (APTENSIO XR, CONCERTA, DAYTRANA [TRANSDERMAL], METADATE CD, METADATE ER, METHYLIN ER, QUILLICHEW, QUILLIVANT XR, RITALIN LA)

Copyright © 2017 Public Citizen's Health Research Group. All rights reserved. https://www.worstpills.org/